InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the detailed record of transactions filed by Yelensky Roman, Executive. Director active across 1 company, notably Gritstone bio, Inc.. Aggregated, 6 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €366k. History available since 19 January 2021. The latest transaction was disclosed on 7 January 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
27,400 shares0Common StockSEC:0001567619-21-020876:0
10,000 shares@ US$22.102985.0% of flowCommon StockSEC:0001567619-21-020893
50,724 shares@ US$0.75915.0% of flowCommon StockSEC:0001567619-21-020894
27,400 shares0Common StockSEC:0001567619-21-020876
50,724 shares@ US$0.7597.5% of flowCommon StockSEC:0001567619-21-020894:0
10,000 shares@ US$22.102942.5% of flowCommon StockSEC:0001567619-21-020893:0
6 of 6 declarations
About Yelensky Roman
Roman Yelensky is an executive at Gritstone bio, Inc. While his role is not specified, he is involved in the company's leadership, which focuses on developing immunotherapeutic treatments. Roman contributes to Gritstone's mission of transforming healthcare through innovation.
